Tudor Investment Corp
ABUS icon

Tudor Investment Corp’s Arbutus Biopharma ABUS Stock Holding History

Tudor Investment Corp’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100,000
Closed -$2.11M – 1420
2014
Q3 		$2.11M Buy
+100,000
New +$1.63M 0.08% 126

Other funds holding ABUS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Tudor Investment Corp's ABUS Position: Q4 2014 in Review

Tudor Investment Corp sold out of Arbutus Biopharma (ABUS) in Q4 2014, closing a stake of 100,000 shares — an estimated $2.11M sold.

Tudor Investment Corp first reported a position in ABUS in Q3 2014 and held it in 1 quarter. The position peaked at $2.11M in Q3 2014. 49 funds tracked by Wall St. Rank hold ABUS as of Q4 2014.

  • Tudor Investment Corp reported no remaining Arbutus Biopharma position as of Q4 2014 after selling out during the quarter.
  • Tudor Investment Corp sold 100,000 Arbutus Biopharma shares in Q4 2014, an estimated $2.11M.
  • Tudor Investment Corp first reported a position in Arbutus Biopharma in Q3 2014 and held it in 1 quarter.
  • Tudor Investment Corp's Arbutus Biopharma position peaked at $2.11M in Q3 2014.
  • 49 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2014.

Based on Tudor Investment Corp's 13F filing for Q4 2014, filed 17 Feb 2015.